Buscar
27/01/2022
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19
Collazos, J, Domingo, P, Fernandez-Araujo, N, Asensi-Diaz, E, Vilchez-Rueda, H, Lalueza, A, Roy-Vallejo, E, Blanes, R, Raya-Cruz, M, Sanz-Canovas, J, Artero, A, Ramos-Rincon, JM, Duenas-Gutierrez, C, Lamas-Ferreiro, JL, Asensi, V. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1)DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3.700(Q2/4D).
26/01/2022
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
Soto, I, Mateo, J, Garcia-Diego, DA, Gil, B, Ruiz-Beato, E, Ivanova, Y, Lorenzo, TM, Maravilla-Herrera, P, Hidalgo-Vega, A, Merino, M. The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. BMC HEALTH SERVICES RESEARCH. 2022; 22(1)DOI:10.1186/s12913-021-07447-4. PMID:35081958. IF:2.800(Q3/6D).
24/01/2022
Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification
Rodriguez-Temporal, D, Alcaide, F, Marekovic, I, O'Connor, JA, Gorton, R, van Ingen, J, Van den Bossche, A, Hery-Arnaud, G, Beauruelle, C, Orth-Holler, D, Palacios-Gutierrez, JJ, Tudo, G, Bou, G, Ceyssens, PJ, Garrigo, M, Gonzalez-Martin, J, Greub, G, Hrabak, J, Ingebretsen, A, Mediavilla-Gradolph, MC, Oviano, M, Palop, B, Pranada, AB, Quiroga, L, Ruiz-Serrano, MJ, Rodriguez-Sanchez, B. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-05315-7. PMID:35075208. IF:4.600(Q2/4D).
21/01/2022
Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
Abdelnour, C, Ferreira, D, van de Beek, M, Cedres, N, Oppedal, K, Cavallin, L, Blanc, F, Bousiges, O, Wahlund, LO, Pilotto, A, Padovani, A, Boada, M, Pagonabarraga, J, Kulisevsky, J, Aarsland, D, Lemstra, AW, Westman, E. Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-021-00946-w. PMID:35063023. IF:9.000(Q1/1D).
21/01/2022
Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)
Paramo, JA, Lozano, ML, Gonzaalez-Porras, JR, Mateo, J. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). MEDICINA CLINICA. 2022; 158(2)DOI:10.1016/j.medcli.2021.05.020. PMID:34311973. IF:3.900(Q2/4D).
18/01/2022
Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study
Mauricio, D, Vlacho, B, de la Puente, JB, Mundet-Tuduri, X, Real, J, Kulisevsky, J, Ortega, E, Castelblanco, E, Julve, J, Franch-Nadal, J. Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study. Frontiers in Medicine. 2022; 8DOI:10.3389/fmed.2021.800973. PMID:35118094. IF:3.900(Q2/4D).
18/01/2022
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
Reyes-Leiva, D, Dols-Icardo, O, Sirisi, S, Cortes-Vicente, E, Turon-Sans, J, De Luna, N, Blesa, R, Belbin, O, Montal, V, Alcolea, D, Fortea, J, Lleo, A, Rojas-Garcia, R, Illan-Gala, I. Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology. 2022; 12DOI:10.3389/fneur.2021.750543. PMID:35115992. IF:3.400(Q2/5D).
15/01/2022
A new tool to screen patients with severe obstructive sleep apnea in the primary care setting: a prospective multicenter study
Peñacoba P., Llauger M.A., Fortuna A.M., Flor X., Sampol G., Pedro-Pijoan A.M., Grau N., Santiveri C., Juvanteny J., Aoiz J.I., Bayó J., Lloberes P., Mayos M., Domínguez Olivera L., Valverde Trillo P., Santos Santos M.ªÁ., Farga Martínez M.ªM., Reverté Simó M., Argemí Saburit N., Medrano Medrano C., Puig García M.. A new tool to screen patients with severe obstructive sleep apnea in the primary care setting: a prospective multicenter study. BMC Pulmonary Medicine. 2022; 22(1)DOI:10.1186/s12890-022-01827-0. PMID:35033055. IF:3.100(Q3/7D).
15/01/2022
Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study
Hentrich, MU, Bower, M, Daugaard, G, Dieing, A, Bickel, M, Berretta, M, Lesmeister, F, Jurinovic, V, Stoehr, A, Heinzelbecker, J, Krznaric, I, Dieckmann, KP, Necchi, A, Rey, PM, Rockstroh, JK, Brito, M, Pfister, D, Hoffmann, C. Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study. CANCER. 2022; 128(2)DOI:10.1002/cncr.33928. PMID:34592009. IF:6.200(Q1/3D).
12/01/2022
Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
Calvet, J, Berenguer-Llergo, A, Gay, M, Massanella, M, Domingo, P, Llop, M, Sanchez-Jimenez, E, Arevalo, M, Carrillo, J, Albinana, N, Arauz-Garofalo, G, Orellana, C, Delgado, JF, Serrano, A, Llobell, A, Graell, E, Garcia-Manrique, M, Moreno, M, Galisteo, C, Casado, E, Navarro, N, Gomez, A, Garcia-Cirera, S, Rusinol, M, Costa, E, Clotet, B, Vilaseca, M, Blanco, J, Gratacos, J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4.600(Q2/4D).
11/01/2022
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
Wieduwilt, MJ, Metheny, L, Zhang, MJ, Wang, HL, Estrada-Merly, N, Marks, DI, Al-Homsi, AS, Muffly, L, Chao, N, Rizzieri, D, Gale, RP, Gadalla, SM, Cairo, M, Mussetti, A, Gore, S, Bhatt, VR, Patel, SS, Michelis, FV, Inamoto, Y, Badawy, SM, Copelan, E, Palmisiano, N, Kharfan-Dabaja, MA, Lazarus, HM, Ganguly, S, Bredeson, C, Perez, MAD, Cassaday, R, Savani, BN, Ballen, K, Martino, R, Wirk, B, Bacher, U, Aljurf, M, Bashey, A, Murthy, HS, Yared, JA, Aldoss, I, Farhadfar, N, Liu, HT, Abdel-Azim, H, Waller, EK, Solh, M, Seftel, MD, van der Poel, M, Grunwald, MR, Liesveld, JL, Kamble, RT, McGuirk, J, Munker, R, Cahn, JY, Lee, JW, Freytes, CO, Krem, MM, Winestone, LE, Gergis, U, Nathan, S, Olsson, RF, Verdonck, LF, Sharma, A, Ringden, O, Friend, BD, Cerny, J, Choe, H, Chhabra, S, Nishihori, T, Seo, S, George, B, Baxter-Lowe, LA, Hildebrandt, GC, de Lima, M, Litzow, M, Kebriaei, P, Hourigan, CS, Abid, MB, Weisdorf, DJ, Saber, W. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood Advances. 2022; 6(1)DOI:10.1182/bloodadvances.2021004916. PMID:34547770. IF:7.500(Q1/2D).
10/01/2022
Target selection for deep brain stimulation in treatment resistant schizophrenia
Corripio, I, Roldan, A, McKenna, P, Sarro, S, Alonso-Solis, A, Salgado, L, Alvarez, E, Molet, J, Pomarol-Clotet, E, Portella, M. Target selection for deep brain stimulation in treatment resistant schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022; 112DOI:10.1016/j.pnpbp.2021.110436. PMID:34517055. IF:5.600(Q1/2D).
10/01/2022
"No one should be alone in living this process": trajectories, experiences and user's perceptions about quality of abortion care in a telehealth service in Chile
Larrea, S, Hidalgo, C, Jacques-Avino, C, Borrell, C, Palencia, L. "No one should be alone in living this process": trajectories, experiences and user's perceptions about quality of abortion care in a telehealth service in Chile. Sexual and Reproductive Health Matters. 2022; 29(3)DOI:10.1080/26410397.2021.1948953. PMID:34252017. IF:6.000(Q1/1D).
10/01/2022
Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018
Mata-Cases, M, Vlacho, B, Real, J, Puig-Treserra, R, Bundo, M, Franch-Nadal, J, Mauricio, D. Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018. Frontiers in Endocrinology. 2022; 12DOI:10.3389/fendo.2021.810757. PMID:35082758. IF:5.200(Q1/3D).
07/01/2022
A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment
Banas, MC, Bohmig, GA, Viklicky, O, Rostaing, LP, Jouve, T, Guirado, L, Facundo, C, Bestard, O, Grone, HJ, Kobayashi, K, Hanzal, V, Putz, FJ, Zecher, D, Bergler, T, Neumann, S, Rothe, V, Santamaria, ASG, Schiffer, E, Banas, B. A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment. Frontiers in Medicine. 2022; 8DOI:10.3389/fmed.2021.780585. PMID:35071266. IF:3.900(Q2/4D).
07/01/2022
Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events
Cubedo, J, Padro, T, Vilahur, G, Crea, F, Storey, RF, Sendon, JLL, Kaski, JC, Sionis, A, Sans-Rosello, J, Fernandez-Peregrina, E, Gallinat, A, Badimon, L. Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events. EUROPEAN HEART JOURNAL. 2022; 43(2)DOI:10.1093/eurheartj/ehab691. PMID:34580705. IF:39.300(Q1/1D).
02/01/2022
Validity of the Sedentary Behavior Questionnaire in European Older Adults Using English, Spanish, German and Danish Versions
Sansano-Nadal, O, Wilson, JJ, Martin-Borras, C, Brond, JC, Skjodt, M, Caserotti, P, Figuls, MRI, Blackburn, NE, Klenk, J, Rothenbacher, D, Guerra-Balic, M, Font-Farre, M, Denkinger, M, Coll-Planas, L, Deidda, M, McIntosh, E, Gine-Garriga, M, Tully, MA. Validity of the Sedentary Behavior Questionnaire in European Older Adults Using English, Spanish, German and Danish Versions. Measurement in Physical Education and Exercise Science. 2022; 26(1)DOI:10.1080/1091367X.2021.1922910. PMID:. IF:2.100(Q3/7D).
02/01/2022
Establishment and validation of surface model for biodosimetry based on gamma-H2AX foci detection
Lopez, JS, Pujol-Canadell, M, Puig, P, Ribas, M, Carrasco, P, Armengol, G, Barquinero, JF. Establishment and validation of surface model for biodosimetry based on gamma-H2AX foci detection. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. 2022; 98(1)DOI:10.1080/09553002.2022.1998706. PMID:34705602. IF:2.600(Q1/3D).
02/01/2022
Bilateral Marginal Corneal Infiltrates: A Novel Ocular Manifestation of DRESS Syndrome
Vela, JI, Bulnes, V, Torrell, N, Giro, M, Perich, S. Bilateral Marginal Corneal Infiltrates: A Novel Ocular Manifestation of DRESS Syndrome. OCULAR IMMUNOLOGY AND INFLAMMATION. 2022; 30(1)DOI:10.1080/09273948.2020.1797111. PMID:32816571. IF:3.300(Q2/3D).
02/01/2022
A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Lopez-Guillermo, A, Canales, MA, Dlouhy, I, Mercadal, S, Briones, J, Garcia-Sancho, AM, Sancho, JM, Moraleda, JM, Terol, MJ, Salar, A, Palomera, L, Gardella, S, Jarque, I, Ferrer, S, Bargay, J, Lopez, A, Panizo, C, Muntanola, A, Montalban, C, Conde, E, Hernandez, MT, Soler, A, Marco, JAG, Deben, G, Marin, J, Tomas, JF. A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. LEUKEMIA & LYMPHOMA. 2022; 63(1)DOI:10.1080/10428194.2021.1971216. PMID:34459702. IF:2.600(Q3/7D).
01/01/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy
Martín-Aguilar L, Lleixà C, Pascual-Goñi E, Caballero-Ávila M, Martínez-Martínez L, Díaz-Manera J, Rojas-García R, Cortés-Vicente E, Turon-Sans J, de Luna N, Suárez-Calvet X, Gallardo E, Rajabally Y, Scotton S, Jacobs BC, Baars A, Cortese A, Vegezzi E, Höftberger R, Zimprich F, Roesler C, Nobile-Orazio E, Liberatore G, Hiew FL, Martínez-Piñeiro A, Carvajal A, Piñar-Morales R, Usón-Martín M, Albertí O, López-Pérez MÁ, Márquez F, Pardo-Fernández J, Muñoz-Delgado L, Cabrera-Serrano M, Ortiz N, Bartolomé M, Duman Ö, Bril V, Segura-Chávez D, Pitarokoili K, Steen C, Illa I, Querol L. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. Neurology-Neuroimmunology & Neuroinflammation. 2022; 9(1)DOI:10.1212/NXI.0000000000001098. PMID:34728497. IF:8.800(Q1/1D).
01/01/2022
Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia
Caballero-Ávila M., Álvarez-Velasco R., Moga E., Rojas-Garcia R., Turon-Sans J., Querol L., Olivé M., Reyes-Leiva D., Illa I., Gallardo E., Cortés-Vicente E.. Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia. NEUROMUSCULAR DISORDERS. 2022; 32(8)DOI:10.1016/j.nmd.2022.06.006. PMID:35811274. IF:2.800(Q3/6D).
01/01/2022
Azathioprine therapy induces selective NK cell depletion and IFN-? deficiency predisposing to herpesvirus reactivation
Ingelfinger F., Sparano C., Bamert D., Reyes-Leiva D., Sethi A., Rindlisbacher L., Zwicky P., Kreutmair S., Widmer C.C., Mundt S., Cortés-Vicente E., Tugues S., Becher B., Schreiner B.. Azathioprine therapy induces selective NK cell depletion and IFN-? deficiency predisposing to herpesvirus reactivation. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022; 151(1)DOI:10.1016/j.jaci.2022.09.010. PMID:36122787. IF:14.200(Q1/1D).
01/01/2022
Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management
Bolano-Diaz, C, Diaz-Manera, J. Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management. Therapeutics and Clinical Risk Management. 2022; 18DOI:10.2147/TCRM.S334232. PMID:36536827. IF:2.800(Q3/6D).
01/01/2022
The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
Querol L.A., Hartung H.-P., Lewis R.A., van Doorn P.A., Hammond T.R., Atassi N., Alonso-Alonso M., Dalakas M.C.. The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies. Neurotherapeutics. 2022; 19(3)DOI:10.1007/s13311-022-01221-y. PMID:35378684. IF:5.700(Q1/2D).
01/01/2022
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach
Mayhew A.G., James M.K., Moore U., Sutherland H., Jacobs M., Feng J., Lowes L.P., Alfano L.N., Muni Lofra R., Rufibach L.E., Rose K., Duong T., Bello L., Pedrosa-Hernández I., Holsten S., Sakamoto C., Canal A., Sánchez-Aguilera Práxedes N., Thiele S., Siener C., Vandevelde B., DeWolf B., Maron E., Gordish-Dressman H., Hilsden H., Guglieri M., Hogrel J.-Y., Blamire A.M., Carlier P.G., Spuler S., Day J.W., Jones K.J., Bharucha-Goebel D.X., Salort-Campana E., Pestronk A., Walter M.C., Paradas C., Stojkovic T., Mori-Yoshimura M., Bravver E., Díaz-Manera J., Pegoraro E., Mendell J.R., Straub V.. Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.828525. PMID:35359643. IF:3.400(Q2/5D).
01/01/2022
Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score
Doets A.Y., Lingsma H.F., Walgaard C., Islam B., Papri N., Davidson A., Yamagishi Y., Kusunoki S., Dimachkie M.M., Waheed W., Kolb N., Islam Z., Mohammad Q.D., Harbo T., Sindrup S.H., Chavada G., Willison H.J., Casasnovas C., Bateman K., Miller J.A.L., van den Berg B., Verboon C., Roodbol J., Leonhard S.E., Benedetti L., Kuwabara S., van den Bergh P., Monges S., Marfia G.A., Shahrizaila N., Galassi G., Péréon Y., Bürmann J., Kuitwaard K., Kleyweg R.P., Marchesoni C., Sedano Tous M.J., Querol L., Illa I., Wang Y., Nobile-Orazio E., Rinaldi S., Schenone A., Pardo J., Vermeij F.H., Lehmann H.C., Granit V., Cavaletti G., Gutiérrez-Gutiérrez G., Barroso F.A., Visser L.H., Katzberg H.D., Dardiotis E., Attarian S., van der Kooi A.J., Eftimov F., Wirtz P.W., Samijn J.P.A., Jacobus Gilhuis H., Hadden R.D.M., Holt J.K.L., Sheikh K.A., Karafiath S., Vytopil M., Antonini G., Feasby T.E., Faber C.G., Gijsbers C.J., Busby M., Roberts R.C., Silvestri N.J., Fazio R., van Dijk G.W., Garssen M.P.J., Straathof C.S.M., Gorson K.C., Jacobs B.C.. Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score. NEUROLOGY. 2022; 98(5)DOI:10.1212/WNL.0000000000013139. PMID:34937789. IF:9.900(Q1/1D).
01/01/2022
The Parkinson's Disease-Cognitive Rating Scale: Greek Normative Data, Clinical Utility and Cultural Considerations
Aretouli, E, Chondrogiorgi, M, Dede, O, Koutsonida, M, Lafi, C, Konstantinopoulou, E, Kulisevsky, J, Kosmidis, MH, Konitsiotis, S. The Parkinson's Disease-Cognitive Rating Scale: Greek Normative Data, Clinical Utility and Cultural Considerations. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2022; 35(5)DOI:10.1177/08919887211049110. PMID:34663111. IF:2.600(Q3/7D).
01/01/2022
Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review
Sampedro, F, Kulisevsky, J. Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review. JOURNAL OF NEUROIMAGING. 2022; 32(1)DOI:10.1111/jon.12930. PMID:34506674. IF:2.400(Q3/6D).
01/01/2022
An MDS Evidence-Based Review on Treatments for Huntington's Disease
Ferreira, JJ, Rodrigues, FB, Duarte, GS, Mestre, TA, Bachoud-Levi, AC, Bentivoglio, AR, Burgunder, JM, Cardoso, F, Claassen, DO, Landwehrmeyer, GB, Kulisevsky, J, Nirenberg, MJ, Rosser, A, Roth, J, Seppi, K, Slawek, J, Furr-Stimming, E, Tabrizi, SJ, Walker, FO, Vandenberghe, W, Costa, J, Sampaio, C. An MDS Evidence-Based Review on Treatments for Huntington's Disease. MOVEMENT DISORDERS. 2022; 37(1)DOI:10.1002/mds.28855. PMID:34842303. IF:8.600(Q1/1D).
01/01/2022
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
Garcia, DS, Roca, LG, Fonticoba, TD, Bartolome, CC, Rios, LN, Canfield, H, Gonzalez, JMP, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group. Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-212868. PMID:34602501. IF:5.200(Q1/3D).
01/01/2022
MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice
Garcia, DS, Sauco, MA, Calopa, M, Carrillo, F, Sevilla, FE, Freire, E, Ramos, RG, Kulisevsky, J, Esteban, JCG, Legarda, I, Luquin, MRI, Castrillo, JCM, Martinez-Martin, P, Martinez-Torres, I, Mir, P, Ignacio, AS. MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice. Diagnostics. 2022; 12(1)DOI:10.3390/diagnostics12010055. PMID:35054222. IF:3.600(Q2/4D).
01/01/2022
Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Santos García D, Canfield H, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, García Roca L, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P, COPPADIS Study Group. Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Journal of Parkinsons Disease. 2022; 12(3)DOI:10.3233/JPD-213004. PMID:34957949. IF:5.200(Q1/3D).
01/01/2022
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease
Sampedro, F, Martinez-Horta, S, Marin-Lahoz, J, Pagonabarraga, J, Kulisevsky, J. Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease. Journal of Parkinsons Disease. 2022; 12(5)DOI:10.3233/JPD-223223. PMID:35491803. IF:5.200(Q1/3D).
01/01/2022
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021)
Abbruzzese, G, Kulisevsky, J, Bergmans, B, Gomez-Esteban, JC, Kagi, G, Raw, J, Stefani, A, Warnecke, T, Jost, WH. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021). Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-219007. PMID:34275911. IF:5.200(Q1/3D).
01/01/2022
Functional changes in prefrontal cortex following frequency-specific training
Bach-Morrow L., Boccalatte F., DeRosa A., Devos D., Garcia-Sanchez C., Inglese M., Droby A.. Functional changes in prefrontal cortex following frequency-specific training. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-24088-7. PMID:36434008. IF:4.600(Q2/4D).
01/01/2022
Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins
Pou M.A., Orfila F., Pagonabarraga J., Ferrer-Moret S., Corominas H., Diaz-Torne C.. Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins. Revue Du Rhumatisme (edition Francaise). 2022; 89(6)DOI:10.1016/j.rhum.2022.09.019. PMID:. IF:(Q/D).
01/01/2022
Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert
Kulisevsky J.. Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert. REVISTA DE NEUROLOGIA. 2022; 75(s04)DOI:10.33588/rn.75s04.2022217. PMID:36342310. IF:1.200(Q4/10D).
01/01/2022
Efficacy and safety of high doses of safinamide in advanced Parkinson disease
Rodríguez-Jorge F., Beltrán-Corbellini Á., Chico-García J.L., Parra-Díaz P., Baena-Álvarez B., Pagonabarraga J., Pérez-Torre P., Pareés I., López-Sendón J.L., Martínez-Castrillo J.C., Alonso-Cánovas A.. Efficacy and safety of high doses of safinamide in advanced Parkinson disease. PARKINSONISM & RELATED DISORDERS. 2022; 97DOI:10.1016/j.parkreldis.2022.03.010. PMID:35344893. IF:(Q/D).
01/01/2022
The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice
Roch, G, Batalle, G, Bai, X, Pouso-Vazquez, E, Rodriguez, L, Pol, O. The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice. Antioxidants. 2022; 11(1)DOI:10.3390/antiox11010122. PMID:35052626. IF:7.000(Q1/1D).